EPOA response to the Reuters publication on the WHO paper “The palm oil industry and non- communicable diseases”

Posted on: January 22, 2019

INDEPENDENTLY OF THE FINANCIAL SUPPORT, PEER REVIEWED PUBLICATIONS HAVE TO GO THROUGH THE EVALUATION OF SEVERAL OTHER EXPERTS IN THE FIELD BEFORE PUBLICATION

SCIENCE RELATING A SINGLE INGREDIENT TO HEALTH OVERLOOKS THE INFLUENCE OF EATING HABITS, CALORIC INTAKE AND LIFE-STYLE

SUCCESFUL SUSTAINABLE DEVELOPMENT OF PALM OIL IS KEY TO POVERTY ALLEVIATION, WHICH IS AN IMPORTANT GLOBAL DRIVER IN IMPROVING HEALTH

EPOA responded to the Reuters publication: ”WHO study likens palm oil lobbying to tobacco and
alcohol industries” citing the following WHO paper: “The palm oil industry and non-communicable diseases” as follows:

We would like to emphasize that EPOA, the European Palm Oil Alliance, has a high esteem of World Health
Organization, in particular regarding its endeavours to promote healthy life styles and easy access to foods
fitting in that life style. We also view Reuters as a well-informed and balanced news journal.

As an alliance of palm oil refiners and producers committed to supply sustainable palm oil to the European
food market and encouraging sustainable palm oil practices worldwide, EPOA therefore takes any public
WHO concern related to the sustainability and health of palm oil very seriously.

We would like to take this opportunity to explain that both the Reuters publication and the WHO paper
unjustly compare palm oil to the tobacco and alcohol lobby and refer to palm oil as the major cause for risk of
non-communicable diseases such as heart disease. Please find the EPOA statement here.